BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26453135)

  • 1. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.
    Keutgen XM; Nilubol N; Glanville J; Sadowski SM; Liewehr DJ; Venzon DJ; Steinberg SM; Kebebew E
    Surgery; 2016 Jan; 159(1):311-8. PubMed ID: 26453135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ye H; Xu HL; Shen Q; Zheng Q; Chen P
    J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
    Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
    Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
    Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
    World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
    Keutgen XM; Nilubol N; Kebebew E
    Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
    Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
    Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis.
    Hüttner FJ; Schneider L; Tarantino I; Warschkow R; Schmied BM; Hackert T; Diener MK; Büchler MW; Ulrich A
    Langenbecks Arch Surg; 2015 Aug; 400(6):715-23. PubMed ID: 26198970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study.
    Ge L; Li H; Dong L; Shang G; Wang W; Li Y; Qi L; Zhao J; Peng D; Tong G
    Medicine (Baltimore); 2021 Jul; 100(27):e26347. PubMed ID: 34232169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of non-functioning pancreatic neuroendocrine tumours based on three clinical scenarios.
    Busquets J; Ramírez-Maldonado E; Serrano T; Peláez N; Secanella L; Ruiz-Osuna S; Ramos E; Lladó L; Fabregat J
    Cir Esp; 2016 Dec; 94(10):578-587. PubMed ID: 27863693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
    Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
    Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
    Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
    Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection of high-grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival.
    Jiang J; Park J; Kim S; Daan A; Donahue T; Girgis MD
    J Surg Oncol; 2021 Dec; 124(8):1373-1380. PubMed ID: 34406651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis.
    Wiltberger G; Bucher JN; Krenzien F; Benzing C; Atanasov G; Schmelzle M; Hau HM; Bartels M
    BMC Surg; 2015 Dec; 15():126. PubMed ID: 26772176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors.
    Fitzgerald TL; Mosquera C; Vora HS; Vohra NA; Zervos EE
    Am Surg; 2016 Aug; 82(8):737-42. PubMed ID: 27657591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
    Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
    JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
    Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
    Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.